+41 91 682 20 40 info@elixi-int.com

Warning: getimagesize(/home/elixitom/public_html/wp-content/uploads/2016/07/ht_150203_ibrance_75mg_800x600.jpg): failed to open stream: No such file or directory in /home/clients/5f0b4deb973bf941571734948687755e/web/elixi/wp-content/themes/Total/framework/classes/image-resize.php on line 116
Ht 150203 Ibrance 75mg 800x600

IBRANCE® (palbociclib) – Metastatic Breast Cancer

IBRANCE is a prescription medicine used to treat hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer that has spread to other parts of the body (metastatic) in combination with:

  • letrozole as the first hormonal based therapy in women who have gone through menopause, or
  • fulvestrant in women with disease progression following hormonal therapy.

The effectiveness of IBRANCE plus letrozole is based on a study that measured progression-free survival. There is an ongoing study to find out how IBRANCE works in combination with letrozole over a longer period of time.

please contact us for a quotation, this product is available on Name Patient Program and Wholesale Business.